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Chemicals found in the environment have been found to behave like the body's natural 
estrogen, estradiol. These exogenous estrogen-mimicking compounds have been termed 
xenoestrogens. Both estradiol and xenoestrogens can bind two estrogen receptors (ERs), ER 
alpha and ER beta, to elicit biological responses. The receptors are ligand inducible 
transcription factors that exhibit unique biological actions. While estradiol binds both receptors 
equally, some xenoestrogens have been shown to bind ER beta preferentially. When the ER is 
bound, the ligand induces a unique ER shape and in turn causes an array of tissue-specific 
biological responses. For example, the ligand tamoxifen, a commonly used breast cancer 
pharmaceutical, exhibits an ER antagonist response in the breast and an ER agonist response 
in the bone. This dual ligand quality characterizes what is now known as a selective estrogen 
receptor modulator (SERM). Peptide profiling, a novel ER ligand screening assay, is a method 
that can potentially identify SERMS by correlating in vitro ER conformation with in vivo biological 
response. Each ligand is screened using a two-hybrid fusion protein reporter gene assay. Upon 
ligand binding, the ER assumes a conformation; with this induced shape, some ER-interacting 
peptides will be able to bind while others will not. After screening a ligand against a library of 
fifteen different peptides, a unique peptide profile will figuratively illustrate the induced ER 
conformation. Eight xenoestrogens were screened in this experiment: estradiol, a natural 
physiological estrogen; resveratrol and genistein, two phytoestrogens; MPP, bisphenol A, and 4-
hydroxytamoxifen, all synthetic estrogens; α-endosulfan and methoxychlor, both insecticides 
used on crops. Each ligand was found to have a unique peptide profile and, implicitly, a distinct 
ER conformation. The next step will be to determine each ligand’s tissue specific activity and 
identify the unique peptide fingerprint that predicts its in vivo biological response. By correlating 
a ligand’s tissue specific estrogenic activity with its unique ER conformation, peptide profiling 
will not only further elucidate tissue-specific ER activity differences but could also be used as a 
high-throughput screening tool for other potential environmental xenoestrogens and identify 
novel therapeutic SERMs. 
